CIK: 0001674712 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Aug 15, 2016
Total Value ($000): $366,183 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Sagent Pharmaceuticals, Inc. | 6,495,416 | $97,301 | 26.6% | $12.17 | — | Common | 786692103 |
| ACRS | Aclaris therapeutics | 4,191,397 | $77,415 | 21.1% | $19.11 | +3.7% | Common | 00461U105 |
| — | Eiger BioPharmaceuticals | 1,599,591 | $31,704 | 8.7% | $16.77 | — | Common | 28249U105 |
| — | Nabriva Therapeutics AG | 3,151,700 | $23,638 | 6.5% | $8.96 | — | ADR | 62957M104 |
| ASND | Ascendis Pharma | 1,766,832 | $23,446 | 6.4% | $17.51 | — | ADR | 04351P101 |
| CDXS | Codexis, Inc. | 5,573,319 | $22,460 | 6.1% | $3.85 | -5.0% | Common | 192005106 |
| — | Agile Therapeutics, Inc. | 2,019,955 | $15,372 | 4.2% | $6.21 | — | Common | 00847L100 |
| — | Advanced Accelerator Applications S.A. | 455,798 | $13,781 | 3.8% | $35.02 | — | Common | 00790T100 |
| — | Trevena, Inc. | 1,728,000 | $10,886 | 3.0% | $7.67 | — | Common | 89532E109 |
| — | Capnia, Inc. | 7,456,984 | $8,650 | 2.4% | $1.19 | — | Common | 14066L105 |
| — | Aimmune Therapeutics, Inc. | 763,009 | $8,256 | 2.3% | $10.82 | — | Common | 00900T107 |
| RGNX | Regenxbio Inc. | 990,449 | $7,924 | 2.2% | $12.80 | -13.3% | Common | 75901B107 |
| — | Akari Therapeutics Plc | 527,842 | $7,121 | 1.9% | $14.00 | — | ADR | 00972G108 |
| — | Dynavax Technologies Corporation | 359,828 | $5,246 | 1.4% | $19.24 | — | Common | 268158201 |
| — | ProNAi Therapeutics, Inc. | 2,438,270 | $4,852 | 1.3% | $6.74 | — | Common | 74346L101 |
| — | Carbylan Therapeutics | 4,204,562 | $2,775 | 0.8% | $0.64 | — | Common | 141384107 |
| — | Minerva Neurosciences, Inc. | 200,000 | $2,042 | 0.6% | $10.21 | — | Common | 603380106 |
| — | MEI Pharma, Inc. | 1,101,129 | $1,498 | 0.4% | $1.26 | — | Common | 55279B202 |
| — | ReVance Therapeutics, Inc. | 77,373 | $1,052 | 0.3% | $24.38 | — | Common | 761330109 |
| — | Ocera Therapeutics, Inc. | 153,331 | $291 | 0.1% | $2.94 | — | Common | 67552A108 |
| — | Capnia, Inc. | 943,858 | $245 | 0.1% | $0.23 | — | Warrant | 14066L113 |
| — | Zosano Pharma Corp | 98,515 | $125 | 0.0% | $2.30 | — | Common | 98979H103 |
| — | Palatin Technologies, Inc. | 234,909 | $103 | 0.0% | $0.54 | — | Common | 696077403 |